In the last trading session, 2.39 million shares of the Processa Pharmaceuticals Inc (NASDAQ:PCSA) were traded, and its beta was 1.33. Most recently the company’s share price was $0.25, and it changed around $0.02 or 6.30% from the last close, which brings the market valuation of the company to $1.30M. PCSA currently trades at a discount to its 52-week high of $3.10, offering almost -1140.0% off that amount. The share price’s 52-week low was $0.15, which indicates that the current value has risen by an impressive 40.0% since then.

Processa Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended PCSA as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.

Processa Pharmaceuticals Inc (NASDAQ:PCSA) trade information

Instantly PCSA has showed a green trend with a performance of 6.30% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.2679 on recent trading dayincreased the stock’s daily price by 6.68%. The company’s shares are currently down -72.14% year-to-date, but still up 4.63% over the last five days. On the other hand, Processa Pharmaceuticals Inc (NASDAQ:PCSA) is -21.22% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $9, which translates to bulls needing to increase their stock price by 97.22% from its current value. Analyst projections state that PCSA is forecast to be at a low of $9 and a high of $9.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 22.65%. Processa Pharmaceuticals Inc earnings are expected to increase by 75.19% in 2025, but the outlook is positive 42.65% per year for the next five years.

PCSA Dividends

Processa Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in June.

VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 24.43 shares worth $6015.0, making up 0.46% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held roughly 16.5 shares worth around $4061.0, which represents about 0.31% of the total shares outstanding.